ORCID – ResearcherID

(+33) 03 88 27 53 67




Liste des publications :


Beau-Faller, M., Pencreach, E., Leduc, C., Blons, H., Merlio, J.-P., Bringuier, P.-P., de Fraipont, F., Escande, F., Lemoine, A., Ouafik, L., Denis, M., Hofman, P., Lacave, R., Melaabi, S., Langlais, A., Missy, P., Morin, F., Moro-Sibilot, D., Barlesi, F., … French Cooperative Thoracic Intergroup (IFCT). (2019). Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project. Lung Cancer (Amsterdam, Netherlands), 140, 19–26. https://doi.org/10.1016/j.lungcan.2019.10.013
Baldacci, S., Figeac, M., Antoine, M., Descarpentries, C., Kherrouche, Z., Jamme, P., Copin, M.-C., Tulasne, D., Nanni, I., Beau-Faller, M., Melaabi, S., Levallet, G., Quoix, E., Moro-Sibilot, D., Friard, S., Missy, P., Barlesi, F., Cadranel, J., & Cortot, A. B. (2019). Brief report : High MET overexpression does not predict the presence of MET exon 14 splice mutations in NSCLC : results from the IFCT Predict.amm study. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer. https://doi.org/10.1016/j.jtho.2019.09.196
Flippot, R., Biondani, P., Auclin, E., Xiao, D., Hendriks, L., Le Rhun, E., Leduc, C., Beau-Faller, M., Gervais, R., Remon, J., Adam, J., Planchard, D., Lavaud, P., Naltet, C., Caramella, C., Le Pechoux, C., Lacroix, L., Gazzah, A., Mezquita, L., & Besse, B. (2019). Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal Metastases. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer, 14(8), 1400–1407. https://doi.org/10.1016/j.jtho.2019.05.007
Beau-Faller, M., Texier, M., Blons, H., Richard, N., Escande, F., Melaabi, S., Lizard, S., De Fraipont, F., Longchampt, E., Morin, F., Zalcman, G., Pignon, J.-P., & Cadranel, J. (2019). Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non-small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2). Clinical Lung Cancer, 20(3), 222–230. https://doi.org/10.1016/j.cllc.2018.12.012
Renaud, S., Guerrera, F., Seitlinger, J., Reeb, J., Voegeli, A.-C., Legrain, M., Mennecier, B., Santelmo, N., Falcoz, P.-E., Quoix, E., Chenard, M.-P., Weingertner, N., Beau-Faller, M., & Massard, G. (2018). KRAS-specific Amino Acid Substitutions are Associated With Different Responses to Chemotherapy in Advanced Non-small-cell Lung Cancer. Clinical Lung Cancer, 19(6), e919–e931. https://doi.org/10.1016/j.cllc.2018.08.005
Emprou, C., Le Van Quyen, P., Jégu, J., Prim, N., Weingertner, N., Guérin, E., Pencreach, E., Legrain, M., Voegeli, A.-C., Leduc, C., Mennecier, B., Falcoz, P.-E., Olland, A., Santelmo, N., Quoix, E., Massard, G., Guenot, D., Chenard, M.-P., & Beau-Faller, M. (2018). SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients. Cancer Medicine, 7(7), 3278–3291. https://doi.org/10.1002/cam4.1545
Renaud, S., Seitlinger, J., Guerrera, F., Reeb, J., Beau-Faller, M., Voegeli, A.-C., Siat, J., Clément-Duchêne, C., Tiotiu, A., Santelmo, N., Costardi, L., Ruffini, E., Falcoz, P.-E., Vignaud, J.-M., & Massard, G. (2018). Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma. Annals of Surgical Oncology, 25(4), 1069–1078. https://doi.org/10.1245/s10434-018-6347-3
Loubière, S., Drezet, A., Beau-Faller, M., Moro-Sibilot, D., Friard, S., Wislez, M., Blons, H., Daniel, C., Westeel, V., Madroszyk, A., Léna, H., Merle, P., Mazières, J., Zalcman, G., Lacave, R., Antoine, M., Morin, F., Missy, P., Barlesi, F., … French Cooperative Thoracic Intergroup (IFCT). (2018). Cost-effectiveness of KRAS,EGFRandALKtesting for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study. The European Respiratory Journal, 51(3), 1701467. https://doi.org/10.1183/13993003.01467-2017
Leduc, C., Merlio, J. P., Besse, B., Blons, H., Debieuvre, D., Bringuier, P. P., Monnet, I., Rouquette, I., Fraboulet-Moreau, S., Lemoine, A., Pouessel, D., Mosser, J., Vaylet, F., Langlais, A., Missy, P., Morin, F., Moro-Sibilot, D., Cadranel, J., Barlesi, F., … French Cooperative Thoracic Intergroup (IFCT). (2017). Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 28(11), 2715–2724. https://doi.org/10.1093/annonc/mdx404
Renaud, S., Falcoz, P.-E., Schaëffer, M., Guenot, D., Romain, B., Olland, A., Reeb, J., Santelmo, N., Chenard, M.-P., Legrain, M., Voegeli, A.-C., Beau-Faller, M., & Massard, G. (2015). Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases. British Journal of Cancer, 113(8), 1206–1215. https://doi.org/10.1038/bjc.2015.327
Weingertner, N., Meyer, N., Voegeli, A.-C., Guenot, D., Renaud, S., Massard, G., Falcoz, P.-E., Olland, A., Mennecier, B., Gaub, M.-P., Lindner, V., Ghnassia, J.-P., Quoix, E., Chenard, M.-P., & Beau-Faller, M. (2015). Correlation between MET protein expression and MET gene copy number in a Caucasian cohort of non-small cell lung cancers according to the new IASLC/ATS/ERS classification. Pathology, 47(4), 320–328. https://doi.org/10.1097/PAT.0000000000000269
Prim, N., Legrain, M., Guerin, E., Mennecier, B., Weingertner, N., Voegeli, A.-C., Guenot, D., Maugard, C. M., Quoix, A.-E., & Beau-Faller, M. (2014). Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients. European Respiratory Review: An Official Journal of the European Respiratory Society, 23(133), 390–392. https://doi.org/10.1183/09059180.00009313
Lecointre, L., Velten, M., Lodi, M., Saadeh, R., Lavoué, V., Ouldamer, L., Bendifallah, S., Koskas, M., Bolze, P. A., Collinet, P., Canlorbe, G., Touboul, C., Huchon, C., Coutant, C., Faller, E., Boisramé, T., Gantzer, J., Martin, D., Baldauf, J. J., … Ballester, M. (2019). Impact of neoadjuvant chemotherapy cycles on survival of patients with advanced ovarian cancer: A French national multicenter study (FRANCOGYN). European Journal of Obstetrics, Gynecology, and Reproductive Biology, 245, 64–72. https://doi.org/10.1016/j.ejogrb.2019.12.001
Santoro, A., Vileno, B., Palacios, Ò., Peris-Díaz, M. D., Riegel, G., Gaiddon, C., Krężel, A., & Faller, P. (2019). Reactivity of Cu(ii)-, Zn(ii)- and Fe(ii)-thiosemicarbazone complexes with glutathione and metallothionein: from stability to dissociation to transmetallation. Metallomics: Integrated Biometal Science, 11(5), 994–1004. https://doi.org/10.1039/c9mt00061e
Brabletz, T., Spaderna, S., Kolb, J., Hlubek, F., Faller, G., Bruns, C. J., Jung, A., Nentwich, J., Duluc, I., Domon-Dell, C., Kirchner, T., & Freund, J.-N. (2004). Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumor environment in malignant tumor progression. Cancer Research, 64(19), 6973–6977. https://doi.org/10.1158/0008-5472.CAN-04-1132